Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;108(1-2):110-4.
doi: 10.1007/BF02245294.

Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

Affiliations

Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

S R Beckett et al. Psychopharmacology (Berl). 1992.

Abstract

The ability of 5-HT1 receptor agonists to modulate a chemically induced defence response has been studied in Lister hooded rats. Microinjections of the excitatory amino acid D,L-homocysteic acid (DLH) in both rostral and caudal dorsal periaqueductal gray matter (PAG) caused explosive motor behaviour characteristic of defence. This behaviour was quantified in terms of response duration, arena revolutions and number of defensive jumps. Direct administration into the PAG of either 5-carboxamidotryptamine (5-CT) or 8-hydroxy-2-(di-n-propylamino) tetralin (8-OHDPAT) produced behaviours (decreased exploratory rearing, dose related onset of flat body posture) indicative of 5-HT1A receptor activation. Pretreatment with either 5-CT or 8-OHDPAT directly in the PAG caused a significant attenuation, and in some cases a complete abolition, of the DLH evoked response. These agonists share high affinity in vitro for the 5-HT1A receptor. Thus the results suggest that in vivo activation of 5-HT1A receptors mediates an antiaversive response with respect to defensive behaviour elicited by specific chemical stimulation of the dorsal PAG.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurosci Lett. 1985 May 23;56(3):311-6 - PubMed
    1. Eur J Pharmacol. 1984 Oct 15;105(3-4):365-8 - PubMed
    1. Eur J Pharmacol. 1989 Feb 28;161(2-3):219-21 - PubMed
    1. Pharmacol Biochem Behav. 1989 Jan;32(1):259-65 - PubMed
    1. Neurosci Lett. 1990 Oct 2;118(1):112-5 - PubMed

Publication types

LinkOut - more resources